Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-04-20Clinical Trial Update: Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment
A completed clinical trial evaluating the efficacy and safety of PRITOR in patients with hypertension who do not tolerate ACE inhibitors, pr…
-
CLINICAL_TRIALS trial_result · 2010-04-16Clinical Trial Update: How to Get a Better Dry Weight in End-stage Renal Disease (ESRD) Population for Improving Blood Pressure Control [NA]
This completed clinical trial investigates whether optimizing dry weight in end-stage renal disease patients improves blood pressure control…
-
FDA approval · 2010-04-15FDA Approved: AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approves the original application for Amlodipine Besylate and Benazepril Hydrochloride from Dr.Reddy's Laboratories Limited for hyperten…
-
CLINICAL_TRIALS trial_result · 2010-04-14Clinical Trial Update: The Effect of Purple Sweet Potato (PSP)-Juice on Liver Enzymes and Blood Pressure [NA]
A completed clinical trial evaluated the effects of Purple Sweet Potato Juice on liver enzymes and blood pressure. The trial was sponsored b…
-
FDA approval · 2010-04-13FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Solco healthcare U.S., LLC)
FDA approved a supplemental application for benazepril hydrochloride submitted by Solco Healthcare U.S., LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-04-13Clinical Trial Update: BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333) [Phase 3]
A Phase 3 trial comparing losartan/hydrochlorothiazide (50/12.5 mg) to valsartan/hydrochlorothiazide (80/12.5 mg) titrated as needed in pati…
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: Effect of Solar Salt Diet in Elderly Hypertensive Patients [Phase 3]
Phase 3 trial investigating the effects of a solar salt diet on blood pressure in elderly patients with hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: Trial of a Nurse Led Hypertension Clinic in Inner City General Practices [NA]
This clinical trial update reports the completion of a study evaluating a nurse-led hypertension clinic in inner-city general practices, spo…
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Olmesartan Pediatric Pharmacokinetic (PK) Study [Phase 1]
This clinical trial update reports the results of a Phase 1 pediatric pharmacokinetic study of olmesartan for hypertension.
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: The Links Between Water and Salt Intake, Body Weight, Hypertension and Kidney Stones: a Difficult Puzzle [NA]
A University of Parma-led clinical trial examines relationships among water and salt intake, body weight, hypertension, and kidney stones; t…
-
FDA approval · 2010-04-09FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for amlodipine besylate (generic). This action confirms the continued availabili…
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: Sildenafil and Exercise Capacity in Hypertension [NA]
A completed clinical trial evaluated whether sildenafil improves exercise capacity in individuals with hypertension.
-
CLINICAL_TRIALS trial_result · 2010-04-08Clinical Trial Update: Renal and Hormonal Effects of Pioglitazone [Phase 4]
Phase 4 study evaluating the renal and hormonal effects of pioglitazone in people with diabetes and hypertension; the trial completed and re…
-
FDA approval · 2010-04-07FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Original Application (Oxford Pharmaceuticals, LLC)
FDA approved the Original Application for amlodipine besylate 2.5 mg by Oxford Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2010-04-07Clinical Trial Update: Clinical Pharmacists Role in the Management of Hypertension in Jordan [NA]
A completed clinical trial evaluating the role of clinical pharmacists in the management of hypertension in Jordan.
-
FDA approval · 2010-04-06FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic combination of losartan potassium and hydrochlorothiazide for hypertension under ANDA 077157.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure [Phase 2, Phase 3]
Phase 2/3 trial evaluating the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension has completed and p…
-
FDA approval · 2010-03-30FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE, a fixed-dose combination of amlodipine besylate and valsartan, submitted by Novarti…
-
FDA approval · 2010-03-30FDA Approved: CARVEDILOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for carvedilol (generic), authorizing the continued marketing of a generic carvedilol product w…
-
CLINICAL_TRIALS research · 2010-03-30Clinical Trial Update: Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics [Phase 4]
Phase 4 clinical trial investigating the effects of valsartan and aliskiren on hemostatic indices in hypertensive individuals with diabetes;…
-
FDA approval · 2010-03-30FDA Approved: MOEXIPRIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's moexipril hydrochloride as an Original Application (ANDA) for a generic version of an ACE inhibitor used to treat hy…
-
FDA approval · 2010-03-29FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) by Novartis Pharmaceuticals Corpor…
-
CLINICAL_TRIALS trial_result · 2010-03-26Clinical Trial Update: The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity) [Phase 2]
The SAPPHIRE Phase 2 trial evaluating systolic and pulse pressure hemodynamic restoration for hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-26Clinical Trial Update: Hemodynamic Assessment of Healthy and Hypertensive Pregnant Women by Non-Invasive Bio-Reactance
A completed clinical trial evaluating non-invasive bio-reactance for hemodynamic assessment in healthy and hypertensive pregnant women.
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension [Phase 3]
A Phase 3 open-label trial compared two telmisartan/amlodipine dose regimens for hypertension; results were posted in 2010.